No Data
Express News | National Medical Products Administration: Deploys pilot work on segmented production reform of biological products.
Sudden Movement Spotlight | Biomedical Class B shares rose in the afternoon, LKYG-B up 30%, institutions bullish on sector further recovery space
Biomedical Class B shares rose in the afternoon, as of the time of publication, Lai Kai Medicine-B rose by 27.88%, to 7.89 Hong Kong dollars; YimingAngke-B rose by 17.91%, to 5.86 Hong Kong dollars; Yasheng Medicine-B rose by 5.74%, to 46.95 Hong Kong dollars.
Who's buying? The A-share market is closed, but the Hong Kong stock market is still going strong! There's a big shift in foreign capital underway.
According to the latest report published by Goldman Sachs, after the People's Bank of China announced easing measures and the September Political Bureau meeting, mainland consumer stocks rebounded strongly by an average of about 32% in the past week.
Express News | Hong Kong stock CRO concept stocks soared at the close, what happened?
IMMUNOTECH-B: 2024 INTERIM REPORT
Holly futures (06978.HK) A-shares stocks trading abnormal volatility.
Holly futures (06978.HK)(001236.SZ) announced that its A-share stocks had deviations in the closing prices for 2 consecutive trading days on the 13th and 18th of this month, with a cumulative deviation of over 20%. According to the relevant provisions of the Shenzhen Stock Exchange's trading rules, this situation belongs to abnormal stock trading volatility. Holly futures stated that the board of directors will verify the relevant issues concerning the company, controlling shareholders, and the actual controller, and pointed out that there is no need to supplement or correct the information disclosed in the previous period; no significant undisclosed information that may or has already had a significant impact on the company's stock trading price has been found in recent public media reports.
No Data
No Data